ALPS ADVISORS INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$2,508,000
+103.2%
36,829
-4.6%
0.02%
+100.0%
Q2 2022$1,234,000
-36.7%
38,620
-49.5%
0.01%
-36.8%
Q3 2021$1,949,000
-31.7%
76,497
-6.2%
0.02%
-24.0%
Q2 2021$2,855,000
-37.3%
81,511
-27.1%
0.02%
-43.2%
Q1 2021$4,556,000
-5.2%
111,795
+0.8%
0.04%
-18.5%
Q4 2020$4,804,000
+11.3%
110,910
+41.7%
0.05%
-15.6%
Q3 2020$4,315,000
-17.8%
78,251
-5.9%
0.06%
-8.6%
Q2 2020$5,248,000
-6.0%
83,128
-23.9%
0.07%
-18.6%
Q1 2020$5,581,000
-42.2%
109,237
-10.0%
0.09%
+14.7%
Q4 2019$9,648,000
+66.2%
121,371
+1.4%
0.08%
+66.7%
Q3 2019$5,805,000
-6.2%
119,641
+1.7%
0.04%
-2.2%
Q2 2019$6,190,000
-12.8%
117,672
-12.3%
0.05%
-8.0%
Q1 2019$7,099,000
+34.8%
134,123
+4.5%
0.05%
+22.0%
Q4 2018$5,268,000
+50.5%
128,325
+39.3%
0.04%
+78.3%
Q3 2018$3,500,000
+3.6%
92,112
+23.3%
0.02%
+4.5%
Q2 2018$3,377,000
+13.3%
74,716
+21.1%
0.02%
-8.3%
Q1 2018$2,980,000
+56.4%
61,706
+27.4%
0.02%
+84.6%
Q4 2017$1,905,000
+42.6%
48,423
+12.6%
0.01%
+44.4%
Q3 2017$1,336,000
+24.0%
43,015
+9.3%
0.01%
+12.5%
Q2 2017$1,077,000
-19.9%
39,366
+7.9%
0.01%
-11.1%
Q1 2017$1,345,000
+159.7%
36,492
+1.8%
0.01%
+125.0%
Q4 2016$518,00035,8610.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders